Zhu, J., Sun, X., Qiao, J., Jia, H., Zhao, Y., Wang, C., Zhang, C., Wei, Y., Sun, Y., Wu, J., Yan, M., Yuan, P., Jia, L., Mao, Q., Wei, L., Jia, G., Li, L., Lu, Z., Chen, X., Liu, Z. (2026). Neoadjuvant pyrotinib vs pertuzumab therapy for HER2-positive early breast cancer: The HELEN HER-013 randomized clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.509